Equity
Equity rose in 2025 from €841,856 to €1.2m.
Equity rose in 2025 from €841,856 to €1.2m.
The micro format states no turnover.
Green is investment, beige is depreciation.
Short-term debts fell from €184,825 to €153,297.
The 2024 accounts came in latest, 98 days after the end of the period.
Higher net result than 95% of companies in human health. The sector median is €59,541, over 21,360 companies.
In July 2024, 3,138 companies had the same profile as NEUROSOM has now. Each dot stands for 8 companies, two years later.
The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,138 companies, not a prediction for NEUROSOM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
| Company | ||||
|---|---|---|---|---|
| NEUROSOM Chaudfontaine | €1.4m | €563,554 | 81.6% | - |
| Dr. Annemieke Milants, radiologie Waasmunster | €1.4m | €558,423 | 88.4% | - |
| Dr. Milo De Decker - Oftalmoloog Londerzeel | €1.3m | €577,431 | 35.9% | - |
| DOKTER GRIET PARMENTIER MOND-, KAAK- EN AANGEZICHTSCHIRURGIE Lanaken | €1.4m | €621,420 | 56.4% | - |
| VAN DEN BRANDE – DE SCHRIJVER Brasschaat | €1.2m | €555,778 | 36.7% | - |
| ASSOCIATION CARDIO-VIE Charleroi | €1.4m | €553,725 | 41.0% | - |
| Dr. Kevin Punie Rotselaar | €1.3m | €503,219 | 80.9% | - |
These companies have the same main activity as NEUROSOM: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.2m and €1.4m, founded between 2022 and 2023.
NEUROSOM files the micro format. That format states no turnover. The gross margin fell from €940,160 in 2023 to €563,554 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.